Phospho-ERKTHR202/Tyr214 is overexpressed in hairy cell leukemia and is a useful diagnostic marker in bone marrow trephine sections

American Journal of Surgical Pathology

Volumn 37, Issue 2, 2013, Pages 305-308

  Warden, Douglas W ^a   Ondrejka, Sarah ^a   Lin, Jeffrey ^a   Durkin, Lisa ^a   Bodo, Juraj ^a   Hsi, Eric D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

BRAF mutation; chronic lymphocytic leukemia; hairy cell leukemia; phospho ERK; phosphoprotein

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; DNA; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR MARKER;

ARTICLE; BONE MARROW CELL; BONE MARROW EXAMINATION; DIFFERENTIAL DIAGNOSIS; ENZYMOLOGY; GENETICS; HAIRY CELL LEUKEMIA; HUMAN; METABOLISM; METHODOLOGY; PATHOLOGY; PHOSPHORYLATION; POINT MUTATION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TUMOR CELL LINE;

BONE MARROW CELLS; BONE MARROW EXAMINATION; CELL LINE, TUMOR; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; LEUKEMIA, HAIRY CELL; PHOSPHORYLATION; POINT MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84872833996     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182712481     Document Type: Article

References (15)

1. Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairycell leukemia. N Engl J Med. 2011;364:2305-2315.
2. Boyd EM, Bench AJ, van t Veer MB, et al. High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies. Br J Haematol. 2011; 155:609-612.
3. Blombery P, Wong SQ, Hewitt CA, et al. Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders. Haematologica. 2012;97:780-783.
4. Lennerz JK, Klaus BM, Marienfeld RB, et al. Pyrosequencing of BRAF V600E in routine samples of hairy cell leukaemia identifies CD5+ variant hairy cell leukaemia that lacks V600E. Br J Haematol. 2012;157:267-269.
5. Arcaini L, Zibellini S, Boveri E, et al. The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. Blood. 2012;119:188-191.
6. Tiacci E, Schiavoni G, Forconi F, et al. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood. 2012;119:192-195.
7. Ewalt M, Nandula S, Phillips A, et al. Real-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukaemia. Hematol Oncol. 2011, December 22. [Epub ahead of print].
8. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008.
9. Bodo J, Durkin L, Hsi ED. Quantitative in situ detection of phosphoproteins in fixed tissues using quantum dot technology. J Histochem Cytochem. 2009;57:701-708.
10. Aboudola S, Murugesan G, Szpurka H, et al. Bone marrow phospho-STAT5 expression in non-CML chronic myeloproliferative disorders correlates with JAK2 V617F mutation and provides evidence of in vivo JAK2 activation. Am J Surg Pathol. 2007; 31:233-239.
11. Zuluaga Toro T, Hsieh FH, Bodo J, et al. Detection of phospho-STAT5 in mast cells: a reliable phenotypic marker of systemic mast cell disease that reflects constitutive tyrosine kinase activation. Br J Haematol. 2007;139:31-40.
12. Langabeer S, Quinn F, O'Brien D, et al. Incidence of the BRAF V600E mutation in chronic lymphocytic leukemia and prolymphocytic leukemia. Leuk Res. 2012;36:483-484.
13. Xi L, Arons E, Navarro W, et al. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood. 2012;119:3330-3332.
14. Bunting KD, Xie XY, Warshawsky I, et al. Cytoplasmic localization of phosphorylated STAT5 in human acute myeloid leukemia is inversely correlated with Flt3-ITD. Blood. 2007;110:2775-2776.
15. Gibson SE, Schade AE, Szpurka H, et al. Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617F. Hum Pathol. 2008;39:1111-1114.